Evidence map›Paper›PMID 42225969›Full record

ArticleNPJ digital medicine2026

Validating the ADFSCI hypotension symptom domain as a scalable patient reported outcome measure in spinal cord injury.

Wenbin Yang, Meagan N Smith, Julien Rimok, Aasta P Gandhi, Nicolas Hankov, Nicolò Macellari, Anouk E J Nijland, Ilse J W van Nes, Léonie Asboth, Jordan Squair and 10 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Wenbin Yang *Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Meagan N Smith *Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Julien RimokDepartment of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Aasta P GandhiDefitech Center for Interventional Neurotherapies (NeuroRestore), CHUV/UNIL/EPFL, Lausanne, Switzerland.
Nicolas HankovDepartment of Clinical Neuroscience, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Nicolò MacellariDefitech Center for Interventional Neurotherapies (NeuroRestore), CHUV/UNIL/EPFL, Lausanne, Switzerland.
Anouk E J NijlandDepartment of Research, Sint Maartenskliniek, Nijmegen, The Netherlands.
Ilse J W van NesDepartment of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Léonie AsbothDepartment of Clinical Neuroscience, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Jordan SquairDefitech Center for Interventional Neurotherapies (NeuroRestore), CHUV/UNIL/EPFL, Lausanne, Switzerland.
Jocelyne BlochDefitech Center for Interventional Neurotherapies (NeuroRestore), CHUV/UNIL/EPFL, Lausanne, Switzerland.
Nelleke G LangerakDepartment of Research, Sint Maartenskliniek, Nijmegen, The Netherlands.
Noël L W KeijsersDepartment of Research, Sint Maartenskliniek, Nijmegen, The Netherlands.
Erkan KurtDepartment of Neurosurgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Sungchul HuhDepartment of Rehabilitation Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
Kelly A Larkin-KaiserDepartment of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Jill M WechtSpinal Cord Injury Research Service, James J. Peters VA Medical Center, Bronx, NY, USA.
Stephen L McKennaDepartment of Neurosurgery, Stanford Medical School, Stanford University, Stanford, CA, USA.
Grégoire CourtineDefitech Center for Interventional Neurotherapies (NeuroRestore), CHUV/UNIL/EPFL, Lausanne, Switzerland.
Aaron A PhillipsDepartment of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. aaron.phillips@ucalgary.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypotension is an under-recognized consequence of spinal cord injury (SCI). Clinical assessments, such as head-up tilt testing, are resource-intensive and carry safety risks. In this study, we evaluated the validity of the hypotension symptom domain of the Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) questionnaire as a patient-reported outcome measure for hypotension-related symptoms in individuals with SCI. Known-groups validity and convergent validity were supported by higher hypotension symptom scores in participants with physiologically defined orthostatic hypotension (OH). Discriminative performance for OH classification was acceptable, and symptom frequency, severity, and contextual triggers were each associated with greater physiological BP instability. Symptom-level analyses identified blurred vision, light-headedness, fatigue, weakness, and dizziness correlated with blood pressure declines. To assess real-world applicability, we also analyzed a global dataset of patient-reported ADFSCI responses from individuals with SCI, enabling population-scale characterization of hypotensive symptom burden. In this dataset, higher symptom scores were associated with female sex and higher neurological injury level. Together, these findings provide converging evidence of supporting the validity of the hypotension symptom domain as a scalable measure of hypotension symptom burden in SCI for use in remote assessment and screening.

Identifiers

PMID42225969
PMCPMC13522484

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.